Research Finds Heart Remodeling Rapidly Follows Cardiac Injury
New insights on cardiac pathology reported in The American Journal of Pathology
Philadelphia, PA, September 4, 2012 – Cardiac injury leads to significant structural changes in the heart, including enlargement, excess formation of fibrous growth tissue, and abnormalities of the coronary vasculature. While associated factors have been targeted for therapeutic intervention, the results have been conflicting. Most studies have investigated these changes after six days of injury. However, advanced stages of remodeling have already begun by day seven following injury. New research reveals that morphological changes in response to cardiac injury occur rapidly, with implications for the development of therapeutic strategies. The results are published in the October issue of The American Journal of Pathology.
“We analyzed and have demonstrated for the first time the early interaction and coordination of morphological changes, cell populations, and gene expression following pathological cardiac insult,” reports lead investigator Troy A. Baudino, PhD, of the Cardiovascular Research Institute at Texas A&M Health Science Center, Temple, TX. “The time course of our study allows these events to be correlated to one another, providing valuable insight for future studies of cardiac pathology.”
The investigators induced heart injury in mice through transverse aortic constriction (TAC). A control group of mice underwent a surgical procedure without the aortic constriction, for comparison. They evaluated acute cardiac modeling events beginning two days after surgery, including changes in hypertrophy, collagen deposition, capillary density, and cell populations.
Within 48 hours after injury, the left ventricular free wall and septum were significantly enlarged, with an increase in heart weight and relative wall thickness compared to controls. In addition to this hypertrophy, a significant decrease in capillary density was observed two days after TAC. Increased levels of pericytes, which are connective tissue cells in small blood vessels, were associated with the reduction in capillary density, supporting earlier research that suggested a role for pericytes in stabilizing vessels and minimizing vascular remodeling. “The participation of pericytes could mark the period where degradation transitions to new capillary formation and re-vascularization,” says Dr. Baudino.
Investigators observed increased fibroblasts and collagen seven days following TAC, contributing to the increased heart weight between two and seven days after injury. “We found that these changes take place concurrently with vascular re-growth,” says Dr. Baudino. “It is possible that while the expanding fibroblast population is depositing excess extracellular material, a process that stiffens the heart, it also simultaneously stimulates capillary growth, to deliver more oxygen and nutrients to the expanding myocardium. Given this implication, regulation of fibroblasts may offer an advantageous route of therapy.”
Dr. Baudino notes that the human response to pressure overload such as hypertension is more gradual than in the TAC mouse model and may vary with respect to the specific timing of remodeling. “Future studies should examine the remodeling events in a clinical setting. However, our results provide a basis for investigating how these events are coordinated during remodeling and the importance of possible intervention before pathological remodeling appears,” he concludes.
# # #
Notes for editors
“Pressure Overload Induces Early Morphological Changes in the Heart,” by Colby Amsden Souders, Thomas Keith Borg, Indroneal Banerjee, and Troy Anthony Baudino ( http://dx.doi.org/10.1016/j.ajpath.2012.06.015). It appears in The American Journal of Pathology, Volume 181, Issue 4 (October 2012) published by Elsevier.
Full text of the article is available to credentialed journalists upon request; contact David Sampson at +1 215 239 3171 or firstname.lastname@example.org. Journalists wishing to interview the authors may contact Troy A. Baudino, PhD, Texas A&M Health Science Center at +1 254 743 0996 or email@example.com.
About The American Journal of Pathology
The American Journal of Pathology ( http://ajp.amjpathol.org), official journal of the American Society for Investigative Pathology, seeks to publish high-quality, original papers on the cellular and molecular biology of disease. The editors accept manuscripts that advance basic and translational knowledge of the pathogenesis, classification, diagnosis, and mechanisms of disease, without preference for a specific analytic method. High priority is given to studies on human disease and relevant experimental models using cellular, molecular, animal, biological, chemical, and immunological approaches in conjunction with morphology.
The leading global forum for reporting quality original research on cellular and molecular mechanisms of disease, The American Journal of Pathology is the most highly cited journal in Pathology – over 38,000 cites in 2011 – with an Impact Factor of 4.890 according to 2011 Journal Citation Reports®, Thomson Reuters.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+1 215 239 3171
Dr. Chhavi Chauhan
The American Journal of Pathology
+1 301 634 7953